相关实验视频

Updated: Jul 4, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

在食道胃腺癌中的当前和未来的生物标志物

Ryan Sappenfield¹, Eric Mehlhaff², Devon Miller²

¹Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, 53792, USA.

Journal of gastrointestinal cancer

|January 27, 2024

概括

本综述强调了食管胃腺癌 (EGA) 的关键生物标志物,包括 HER2 和 PD-L1 等已知标志物,以及 Claudin 18.2.2 等新兴目标. 这些生物标志物指导个性化治疗,改善患者的治疗结果.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
分子诊断学分子诊断学

背景情况:

食管胃腺癌 (EGA) 包含多种不同类型的癌症,需要量身定制的治疗策略.
生物标志物驱动的疗法已经显著改善了各种癌症类型的治疗结果.
了解EGA当前和未来的生物标志物对于推进患者护理至关重要.

研究的目的:

审查食管胃腺癌 (EGA) 的既定和新生物标志物.
讨论目前在临床试验中正在研究的相关疗法.
总结当前关于上部胃肠道癌症生物标志物的知识.

主要方法:

在上部胃肠道癌症中标准和新兴生物标志物的文献综述.
对新生物标志物和相关疗法的临床试验数据的分析.
在EGA.中对基于生物标志物的治疗策略的信息的综合.

主要成果:

已确定的生物标志物 (HER2,PD-L1,MSI/MMR) 允许对EGA进行个性化治疗.
像克劳丁18.2这样的新兴生物标志物显示出有希望的结果,索尔贝图西马布在3期试验中改善了生存率.
新型生物标志物 (FGFR2b,DKN01) 正在临床研究中与相关疗法进行验证.

结论:

生物标志物的发现增强了上部肠道癌症的分类.
以生物标志物为指导的向疗法和免疫疗法为EGA患者提供了更好的结果.
对新生物标志物的持续研究对于进一步的治疗进展至关重要.

关键词:

生物标志物生物标志物克劳迪因 18.2 克劳迪因 DKK1 DKK1 的意思 DKN-01 一个国家.食道癌是食道癌的一个类型.FGFR2bb 的意思是什么?胃癌胃癌是指胃癌.胃食道结口腺癌瘤.在HER2中,HER2是HER2.这是一个MMRMMR.微卫星的不稳定性是微观的在 PDL1 CPS 中使用.

更多相关视频

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion

Published on: July 6, 2022

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

相关概念视频

Barrett Esophagus-I: Introduction

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...